Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
J P KrischerS E Lipshultz

Abstract

To determine the incidence of clinical cardiotoxicity from anthracycline chemotherapy in children with cancer and to identify associated risk factors. The study population consisted of 6,493 children with cancer who had received anthracycline chemotherapy on Pediatric Oncology Group (POG) protocols from 1974 to 1990. Cardiotoxicity, defined as congestive heart failure not due to other causes, abnormal measurements of cardiac function that prompted discontinuation of therapy, or sudden death from presumed cardiac causes, was determined by a review of protocol records. Cardiotoxicity was confirmed in 106 patients (1.6%): 58 had congestive heart failure, 43 had changes in measures of cardiac function that prompted the discontinuation of therapy, and five died suddenly from presumed cardiac causes. In a multivariate analysis, factors that contributed to the relative risk (RR) of toxicity were a cumulative anthracycline dose > or = 550 mg/m2 of body-surface area (RR = 5.2), maximal dose > or = 50 mg/m2 (RR = 2.8), female sex (RR = 1.9), black race (RR = 1.7), presence of trisomy 21 (RR = 3.4), and exposure to amsacrine (RR = 2.6). Cardiotoxicity within 1 year after the completion of anthracycline treatment (early cardiotoxicity) rep...Continue Reading

Citations

Feb 27, 1999·The New England Journal of Medicine·S E LipshultzS D Colan
Aug 6, 1999·Cancer Investigation·K A Tolba, E N Deliargyris
Feb 26, 2000·Pediatric Hematology and Oncology·C K LiP M Yuen
Jan 11, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·J J ReillyB E Gibson
Jan 25, 2002·Blood·Martin S TallmanJacob M Rowe
May 7, 2003·Cancer·Andrea FerrariUNKNOWN Italian Cooperative Group
Apr 26, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Stéphanie HéonLorraine E Chalifour
May 30, 2003·The Oncologist·Joanna L WeinsteinSusan L Cohn
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven E LipshultzSteven D Colan
Mar 30, 2005·Pediatric Blood & Cancer·Jeffrey H Silber
Nov 3, 2005·Nature Clinical Practice. Oncology·Mike M Hawkins
Dec 15, 2005·British Journal of Haematology·Karlijn A WoutersSteven E Lipshultz
Jul 5, 2007·Journal of Pediatric Hematology/oncology·Sivan EksteinMichael Weintraub
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luca GianniDouglas B Sawyer
Nov 22, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Vanessa Gonzalez-CovarrubiasJavier G Blanco
Jun 27, 2012·Pediatric Hematology and Oncology·Maëlle de Ville de GoyetBénédicte Brichard
Sep 20, 2012·Circulation. Cardiovascular Imaging·Steven E LipshultzJames D Wilkinson
Apr 17, 2013·The Pharmacogenomics Journal·F AminkengUNKNOWN Canadian Pharmacogenomics Network for Drug Safety Consortium
Apr 22, 2014·Current Treatment Options in Cardiovascular Medicine·Shashi RajSteven E Lipshultz
Aug 20, 2014·Paediatric Drugs·Steven E LipshultzEric J Chow
Jun 26, 2014·Pediatric Blood & Cancer·J Timothy CaldwellJeffrey W Taub
Nov 5, 2014·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Vivian Wu
May 6, 2015·Pediatric Cardiology·Elżbieta Sadurska
Aug 4, 2015·Nature Genetics·Folefac AminkengUNKNOWN Canadian Pharmacogenomics Network for Drug Safety Consortium
Apr 28, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Natasha N FrederickChristopher J Recklitis
Oct 19, 2016·Journal of Cardiovascular Medicine·Pier P BassareoGiuseppe Mercuro
Jan 16, 2018·JCO Precision Oncology·Bryan P SchneiderKathy D Miller
Aug 25, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Kelsie E OatmenFrancis G Spinale
Sep 21, 2018·American Society of Clinical Oncology Educational Book·Saro Armenian, Smita Bhatia
Jun 11, 2020·Pediatric Blood & Cancer·Diana A SteppanUNKNOWN Pediatric ECMO (PediECMO) subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network and the Extr
Nov 7, 2001·Current Treatment Options in Cardiovascular Medicine·Valeriano C. Simbre IISteven E. Lipshultz
Apr 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D M GreenN E Breslow
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jill P GinsbergJeffrey H Silber
Nov 13, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sukhwinder S LakhmanJavier G Blanco
Mar 30, 2005·Expert Opinion on Drug Safety·Karen Seiter
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John J DoyleDawn L Hershman
Sep 30, 2003·Medical and Pediatric Oncology·Livia KapustaO Daniëls
Oct 21, 2005·Basic & Clinical Pharmacology & Toxicology·Snezana K BjelogrlicSinisa Radulovic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.

Related Papers

Advances in Experimental Medicine and Biology
V J Ferrans
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
L C KremerP A Voûte
Cancer Treatment Reports
M R BristowJ R Daniels
© 2021 Meta ULC. All rights reserved